Today: 1 May 2026

Coupang Stock (CPNG) Slides as CEO Resigns After Record Data Breach – Price, Outlook, and 2026–2027 Forecasts

Coupang Stock (CPNG) Slides as CEO Resigns After Record Data Breach – Price, Outlook, and 2026–2027 Forecasts

Coupang shares fell 3–4% to around $26.10–$26.20 on December 10, 2025, after CEO Park Dae‑jun resigned following a cyberattack that exposed data of 33.7 million users. South Korean authorities raided Coupang’s Seoul offices as investigations intensified. The company’s market cap stood near $47–49 billion. Most analysts maintained “Buy” ratings despite the breach.
10 December 2025
Salesforce (CRM) Stock Today: AI Earnings Beat, Raised FY26 Guidance and 2026 Price Targets – December 10, 2025

Salesforce (CRM) Stock Today: AI Earnings Beat, Raised FY26 Guidance and 2026 Price Targets – December 10, 2025

Salesforce reported fiscal Q3 2026 results that beat expectations, driven by strong AI product growth and cost controls. Shares traded near $260 on December 10, 2025, about 22% lower year-to-date and 29% below the 52-week high. Revenue reached roughly $10.3 billion, with non-GAAP EPS at $3.25 and GAAP net income at $2.1 billion. Market cap stood around $245 billion.
10 December 2025
··
Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Campbell’s shares hit a new 52-week low of $28.13 on December 10, dropping further after a post-earnings slide. Fitch downgraded the company’s credit rating to BBB- with a Stable outlook, citing high leverage and weak trends. Q1 fiscal 2026 results showed sales down 3% and adjusted EPS down 13%, but both slightly beat analyst estimates. Margins fell as tariffs and inflation drove costs higher.
10 December 2025
···
Rocket Lab (RKLB) Stock Today: Neutron Breakthrough, KAIST Launch and 2026 Forecasts Fuel Space Rally

Rocket Lab (RKLB) Stock Today: Neutron Breakthrough, KAIST Launch and 2026 Forecasts Fuel Space Rally

Rocket Lab shares traded near $53.86 midday Wednesday, valuing the company at about $28.8 billion after a volatile year. The firm advanced its next Electron launch for KAIST, carrying the NEONSAT-1A satellite, to no earlier than December 11 in New Zealand. This marks its 19th launch of 2025, surpassing last year’s record. Revenue for the trailing twelve months was $555 million with a net loss of $198 million.
10 December 2025
··
Nauticus Robotics (KITT) Stock on December 10, 2025: Debt Swap, Delisting Risk and High‑Beta Deep‑Sea Ambitions

Nauticus Robotics (KITT) Stock on December 10, 2025: Debt Swap, Delisting Risk and High‑Beta Deep‑Sea Ambitions

Nauticus Robotics exchanged portions of its secured debt for 3,814 shares of new Series C Convertible Preferred Stock with institutional investors on December 3, 2025. The move comes as KITT trades near $1.06–$1.21 per share, with a market cap around $12–16 million and extreme volatility. The company faces a Nasdaq listing deficiency and is attempting to clean up its balance sheet.
10 December 2025
Big Tech Stocks After the Bell on December 10, 2025: Microsoft Surges, Amazon Slips as AI and Fed Jitters Collide

Big Tech Stocks After the Bell on December 10, 2025: Microsoft Surges, Amazon Slips as AI and Fed Jitters Collide

Microsoft rose 2.6% to $491.68 in after-hours trading Wednesday, leading gains among major tech stocks as investors awaited the Federal Reserve’s final rate decision of 2025. Nvidia and Meta also advanced, while Apple and Amazon slipped. The S&P 500 closed flat; the Nasdaq 100 fell 0.2%.
10 December 2025
······
iRobot (IRBT) Stock Today: Short Squeeze Fireworks vs. Bankruptcy Fears – December 10, 2025

iRobot (IRBT) Stock Today: Short Squeeze Fireworks vs. Bankruptcy Fears – December 10, 2025

iRobot shares traded around $4.26 on December 10, 2025, up 20% intraday after speculation about U.S. robotics policy and aggressive short covering. The company’s balance sheet shows shrinking cash, negative equity, and warnings that shareholders could be wiped out without new financing or a buyer. Short interest stands at roughly 40–45% of the float. Market cap is about $110–115 million.
10 December 2025
·
Financial Stocks Today: JPMorgan Shock, Fed Rate Cut Hopes and Crypto Green Light Shape the Sector – December 10, 2025

Financial Stocks Today: JPMorgan Shock, Fed Rate Cut Hopes and Crypto Green Light Shape the Sector – December 10, 2025

JPMorgan warned of $105 billion in 2026 expenses, above Wall Street estimates, sending its shares lower Tuesday. Investors awaited a Federal Reserve rate decision, with markets pricing in a 25-basis-point cut but expecting limited further easing. A new ruling allows U.S. banks to fully offer crypto services. Financial stocks were mixed by midday as Wall Street paused ahead of the Fed announcement.
10 December 2025
···
Energy Stocks After the Bell: XLE Extends Gains as Oil Steadies Around $58 – December 10, 2025 Market Wrap

Energy Stocks After the Bell: XLE Extends Gains as Oil Steadies Around $58 – December 10, 2025 Market Wrap

Energy stocks edged higher Wednesday, with the Energy Select Sector SPDR Fund (XLE) up 0.26% to $45.82, even as crude prices slipped. WTI crude settled at $57.93 per barrel, down 0.55%, and Brent closed near $61.5–62, off 0.6%. Major U.S. equity indices were flat. Traders weighed oversupply concerns and Ukraine peace talks ahead of the Fed’s rate decision.
10 December 2025
··
AI Stocks After the Bell: Oracle’s Earnings, Nvidia’s China Deal and Fed Jitters Shape the Trade on December 10, 2025

AI Stocks After the Bell: Oracle’s Earnings, Nvidia’s China Deal and Fed Jitters Shape the Trade on December 10, 2025

Oracle will report fiscal Q2 results after markets close Wednesday, with investors focused on its AI cloud business and a $300 billion contract with OpenAI. AI-related stocks, including Nvidia and Palantir, traded flat ahead of the release. The S&P 500 slipped 0.2% and the Nasdaq fell 0.5% as traders awaited both Oracle’s earnings and the Federal Reserve’s final 2025 rate decision.
10 December 2025
······
Car, Motorcycle and EV Stocks After the Bell on December 10, 2025: GM Hits Records, Tesla Balances AI Hype and EV ‘Winter’ Fears

Car, Motorcycle and EV Stocks After the Bell on December 10, 2025: GM Hits Records, Tesla Balances AI Hype and EV ‘Winter’ Fears

General Motors hit a record high near $78.04 on December 10, 2025, extending a year-long rally, while Toyota shares rose on activist interest. Rivian and Lucid shares remained volatile as investors weighed concerns over an “EV winter” and policy changes in Europe. Global markets traded cautiously ahead of the U.S. Federal Reserve’s rate decision. Indian and European auto stocks saw mixed moves amid broader market uncertainty.
10 December 2025
·········
BitMine Immersion Technologies (BMNR) Stock on December 10, 2025: 3.86M ETH Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies (BMNR) Stock on December 10, 2025: 3.86M ETH Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies (BMNR) traded around $39 on Dec. 10, after surging nearly 10% the previous session on heavy volume. The company now holds 3.86 million ETH, claiming over 3.2% of global supply, and bought $435 million worth in the past week. Chairman Tom Lee targets 5% of ETH supply, citing a “supercycle” and recent Ethereum network upgrades.
10 December 2025
·
Teva Pharmaceutical Industries (TEVA) Stock: FDA Filing, Analyst Upgrades and 2026–27 Outlook on December 10, 2025

Teva Pharmaceutical Industries (TEVA) Stock: FDA Filing, Analyst Upgrades and 2026–27 Outlook on December 10, 2025

Teva shares traded near $29, close to 52-week highs, after filing a new FDA application for a once-monthly schizophrenia drug and receiving analyst upgrades. Market cap stands at about $32–33 billion. The company reported improved debt ratios and expects consensus 2025 EPS of $2.70. Technical indicators show the stock as overbought but still in an uptrend.
10 December 2025
··
Intel Stock Today: Government Stake, EU Fine Cut and AI Bets Put INTC at a Crossroads (December 10, 2025)

Intel Stock Today: Government Stake, EU Fine Cut and AI Bets Put INTC at a Crossroads (December 10, 2025)

On August 2, 2025, the U.S. government acquired a 10% equity stake in Intel. Intel shares have nearly doubled this year, trading near $40 with a market cap around $193 billion, though Wall Street consensus points to downside. Q3 revenue rose 3% to $13.7 billion, but guidance remains cautious and accounting for government deals is under SEC review.
10 December 2025
··
Galaxy Digital (NASDAQ: GLXY) Stock Soars on AI–Crypto ‘Multi‑Engine’ Growth Story: Latest News, Analyst Targets and 2026 Outlook

Galaxy Digital (NASDAQ: GLXY) Stock Soars on AI–Crypto ‘Multi‑Engine’ Growth Story: Latest News, Analyst Targets and 2026 Outlook

Galaxy Digital shares surged over 11% to just under $30 on December 9, 2025, after Citizens initiated coverage with a $60 price target and a Market Outperform rating. The rally followed record Q3 results, including $505 million in GAAP net income and $728 million in adjusted gross profit, as the company expanded in both digital assets and AI data-center infrastructure.
10 December 2025
···
Eli Lilly (LLY) Stock Near $1 Trillion: Zepbound Price Cuts, New $6B Plant and 2026 Dividend Hike – Is It Still a Buy?

Eli Lilly (LLY) Stock Near $1 Trillion: Zepbound Price Cuts, New $6B Plant and 2026 Dividend Hike – Is It Still a Buy?

Eli Lilly shares traded near $980 midday Monday, after briefly surpassing $1,050 and becoming the first healthcare firm valued above $1 trillion. Q3 revenue rose 54% to $17.6 billion, fueled by Zepbound and Mounjaro sales topping $10 billion. The company announced a $6 billion Alabama plant for its oral weight-loss drug and completed its Adverum Biotechnologies acquisition. LLY trades at about 49 times trailing earnings, far above big-pharma averages.
10 December 2025
··
AutoZone (AZO) Stock Plunges After Q1 2026 Miss: What the Latest Sell-Off Really Means for Investors

AutoZone (AZO) Stock Plunges After Q1 2026 Miss: What the Latest Sell-Off Really Means for Investors

AutoZone shares fell 6.7% Tuesday after fiscal Q1 2026 earnings showed strong sales but weaker margins and profits, marking the stock’s steepest drop since 2022. The decline continued Wednesday, with AZO trading near $3,400, down about 10% since the report. Net sales rose 8.2% to $4.6 billion, but net income dropped to $530.8 million from $564.9 million a year earlier.
10 December 2025
··
Bank of America (BAC) Stock on Fed Cut Watch: Buffett Trims, Wall Street Stays Bullish – December 10, 2025

Bank of America (BAC) Stock on Fed Cut Watch: Buffett Trims, Wall Street Stays Bullish – December 10, 2025

Bank of America shares traded in the mid-$53s Wednesday, near a 52-week high, after Q3 earnings beat estimates and management raised net interest income guidance. Market cap stands near $390 billion, with a trailing P/E ratio in the mid-teens. Warren Buffett continues to reduce his stake. Investment banking fees jumped 43% year-over-year in Q3.
10 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Today: Price, News, Forecast & Schizophrenia NDA Setup – 10 December 2025

Reviva Pharmaceuticals (RVPH) Stock Today: Price, News, Forecast & Schizophrenia NDA Setup – 10 December 2025

Reviva Pharmaceuticals (RVPH) traded around $0.69 per share mid-session December 10, up 10% on the day but still down 72% over the past year. Market cap stood near $78–80 million. On December 9, call options volume spiked 458% above average as traders speculated on upcoming catalysts. The company’s lead drug, brilaroxazine, recently completed Phase 3 trials in schizophrenia.
10 December 2025
··
1 … 1,267 1,268 1,269 1,270 1,271 … 1,889

Stock Market Today

  • Community Financial System (CBU) Stock Gains Momentum Amid Mixed Valuation Signals
    May 1, 2026, 5:21 PM EDT. Community Financial System (CBU) has captured investor attention with its recent share price rising 1.82% in one day and 8.03% over the past month. The stock shows a 1-year total return of 18.79% and a 3-year return of 48.42%, signaling sustained momentum. Trading at $63.36, the bank's price-to-earnings (P/E) ratio stands at 15.2x, above the US Banks industry average of 11.4x and a fair estimate of 14x, indicating potential overvaluation. However, the P/E is below a peer group average of 16.3x. Investors must consider risks including regional bank pressures and potential slowdowns in fee-based segments like wealth and insurance. Valuation models diverge, with discounted cash flow estimates suggesting further analysis is needed to confirm true intrinsic value.

Latest article

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

1 May 2026
Zscaler shares climbed 7% to $139.81 Friday despite a price-target cut by Citizens JMP to $210. The move followed a sector rally after Atlassian raised its forecast. Zscaler reported 26% revenue growth last quarter and expanded AI security features in its GovCloud product. Customers remain cautious on large deals, with longer approval times noted.
Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands

Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands

1 May 2026
Xanadu Quantum Technologies will report first-quarter results May 14, its first earnings since going public last month. Shares closed at $36.12 Friday, up $7.05, with 4.28 million traded. The company posted a $70.7 million net loss in 2025 and raised $302 million via a SPAC merger. Investors will watch the call for updates on spending, cash runway, and funding prospects.
Clorox Stock Slumps After Profit Forecast Cut as Purell Deal and Oil Costs Bite

Clorox Stock Slumps After Profit Forecast Cut as Purell Deal and Oil Costs Bite

1 May 2026
Clorox cut its fiscal 2026 profit forecast, citing higher energy costs, inventory timing, and expenses from its Purell acquisition; shares fell 9.6% to $87.11. The company now expects adjusted EPS of $5.45–$5.65, down from $5.95–$6.30, and organic sales to drop about 9%. Third-quarter sales were flat at $1.67 billion, while gross margin fell to 43.2%.
Go toTop